Skip to main content

Advertisement

Table 1 Intrahepatic recurrence details

From: Successful local treatment for repeated hepatic recurrences of cholangiolocellular carcinoma: a report on a long-term survivor

Recurrence event Interval after primary hepatectomy (months) Recurrence site (size) Treatment Serum CA 19-9 level (U/ml) Serum CEA level (ng/ml)
1 12 S4 (8 mm), S4 (9 mm), S4 (26 mm) S4 partial resection 32 2.8
2 22 S2 (15 mm), S4 (6 mm) RFA 25 2.9
3 26 S2 (22 mm) RFA 29 2.9
4 34 S1 (16 mm), S3 (10 mm) RFA 35 3.4
5 36 S1 (10 mm) RFA 29 2.7
6 41 S3 (7 mm), S3 (7 mm) RFA 29 3.6
7 43 S3 (10 mm) RFA 26 2.9
8 55 S2 (12 mm) RFA 32 3.8
  1. RFA radiofrequency ablation, CA 19-9 carbohydrate antigen 19-9, CEA carcinoembryonic antigen